Caption Management, LLC Biomarin Pharmaceutical Inc Put Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $1.12 Million - $1.38 Million	-15,000 Reduced 26.09%	42,500 $3.5 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $460,955 - $544,500	5,500 Added 10.58%	57,500 $5.02 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $960,372 - $1.24 Million	12,600 Added 31.98%	52,000 $5.01 Million
Q3 2023 Nov 14, 2023	SELL	$85.07 - $94.48 $27.3 Million - $30.3 Million	-320,900 Reduced 89.06%	39,400 $3.49 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $24.3 Million - $28.2 Million	280,900 Added 353.78%	360,300 $31.2 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $8.65 Million - $11.6 Million	-98,600 Reduced 55.39%	79,400 $7.72 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $6.31 Million - $8.47 Million	78,000 Added 78.0%	178,000 $18.4 Million
Q3 2022 Nov 14, 2022	SELL	$82.16 - $96.94 $517,608 - $610,722	-6,300 Reduced 5.93%	100,000 $8.48 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $1.34 Million - $1.63 Million	18,800 Added 21.49%	106,300 $8.81 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $3.34 Million - $4.17 Million	45,000 Added 105.88%	87,500 $6.74 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $3.05 Million - $3.89 Million	42,500 New	42,500 $3.75 Million
Q2 2021 Aug 16, 2021	SELL	$75.51 - $84.79 $9.17 Million - $10.3 Million	-121,400 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $15.2 Million - $18.4 Million	-203,000 Reduced 62.58%	121,400 $9.17 Million
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $10.5 Million - $13 Million	144,400 Added 80.22%	324,400 $28.4 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $8.27 Million - $15.1 Million	115,000 Added 176.92%	180,000 $13.7 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $2.78 Million - $4.35 Million	35,000 Added 116.67%	65,000 $8.02 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $22.2 Million - $30.2 Million	-311,500 Reduced 91.22%	30,000 $2.53 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $19.6 Million - $26.3 Million	304,200 Added 815.55%	341,500 $28.9 Million
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $1.91 Million - $2.23 Million	23,800 Added 176.3%	37,300 $3.19 Million
Q1 2019 May 14, 2019	SELL	$84.2 - $98.62 $2.23 Million - $2.61 Million	-26,500 Reduced 66.25%	13,500 $1.2 Million
Q4 2017 Feb 14, 2018	BUY	$80.76 - $95.13 $3.23 Million - $3.81 Million	40,000	40,000 $3.57 Million

Others Institutions Holding BMRN

# of Institutions

629

Shares Held

178M

Call Options Held

1.98M

Put Options Held

1.17M

Black Rock Inc. New York, NY

22.7M
Shares

$1.49 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19.3M
Shares

$1.26 Billion
0.02% of portfolio
Primecap Management CO Pasadena, CA

18.9M
Shares

$1.24 Billion
0.99% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$912 Million
0.59% of portfolio
Capital Research Global Investors Los Angeles, CA

10.5M
Shares

$688 Million
0.16% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account